Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Telmisartan/Amlodipine and Rosuvastatin
NCT02951962Phase 1Completed
- Sponsor
- Yuhan
- Start
- Aug 2016
- Primary completion
- Sep 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of telmisartan, amlodipine and rosuvastatin in hypertension (HTN) and hyperlipidemia (2 arms), sponsored by Yuhan. Primary endpoints: Area Under the Curve over the dosing interval and Maximum Plasma Concentration. Started Aug 2016; status: completed.
02
Drugs
telmisartanamlodipinerosuvastatin
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT02951962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02951962.